Vanda Pharmaceuticals Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value $40.4m $33.6m $61.0m $45.1m $61.0m $52.1m $135.0m $135.8m $102.3m $84.9m
Prepaid Expense and Other Assets, Current $11.8m $8.0m $12.0m $14.5m $10.1m $12.0m $17.7m $9.2m $15.4m $27.0m
Inventory, Net $779k $840k $994k $1.1m $1.3m $1.0m $1.2m $1.4m $1.7m $1.9m
Assets, Current $174.2m $169.9m $299.1m $354.1m $409.1m $478.3m $519.3m $432.9m $438.9m $347.3m
Property, Plant and Equipment, Net $5.0m $5.3m $4.4m $3.9m $4.1m $3.1m $2.6m $2.0m $2.1m $2.2m
Operating Lease, Right-of-Use Asset $0 $11.2m $10.5m $9.3m $8.4m $7.1m $5.6m $3.9m
Additional Financial Items
Accounts Receivable, after Allowance for Credit Loss, Current $20.3m $17.6m $28.8m $26.4m $30.0m $32.5m $33.5m $34.2m $47.1m $54.6m
AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax ($63k) ($6k) $236k $158k ($207k) ($1.2m) ($51k) $87k $561k
Assets $210.4m $205.4m $332.1m $483.7m $533.5m $593.8m $634.2m $648.4m $656.2m $488.9m
LIABILITIES AND EQUITY
Current liabilities:
Operating Lease, Liability, Current $2.1m $2.1m $2.3m $2.3m $2.4m $2.5m $2.2m
Operating Lease, Liability, Noncurrent $0 $12.5m $11.5m $10.1m $8.8m $7.0m $4.9m $3.0m
Liabilities, Current $50.3m $70.4m $53.0m $59.5m $65.9m $74.4m $91.4m $87.7m $100.0m $145.2m
Other Liabilities, Noncurrent $3.7m $3.7m $3.7m $843k $2.8m $4.4m $6.8m $8.8m $9.6m $9.5m
Deferred Tax Liabilities, Net $29k $15k
Liabilities $79.0m $74.0m $56.7m $72.8m $80.2m $88.9m $107.0m $103.5m $117.7m $161.8m
Stockholders’ equity:
Preferred Stock, Value, Issued $0 $0 $0 $0 $0 $0 $0 $0 $0
Common Stock, Value, Issued $44k $45k $52k $54k $55k $56k $57k $58k $58k $59k
Retained Earnings (Accumulated Deficit) ($345.9m) ($361.4m) ($336.2m) ($220.7m) ($197.3m) ($164.2m) ($157.9m) ($155.4m) ($174.3m) ($394.8m)
Accumulated Other Comprehensive Income (Loss), Net of Tax $58k ($34k) $1k $249k $239k ($175k) ($1.2m) ($30k) $74k $629k
Additional Paid in Capital, Common Stock $477.1m $492.8m $611.6m $631.3m $650.3m $669.2m $686.2m $700.3m $712.7m $721.3m
Stockholders' Equity Attributable to Parent $131.3m $131.4m $275.4m $410.9m $453.3m $504.9m $527.2m $544.9m $538.5m $327.2m
Liabilities and Equity $210.4m $205.4m $332.1m $483.7m $533.5m $593.8m $634.2m $648.4m $656.2m $488.9m